If you are planning pregnancy, discuss this with your doctor as GLP-1 medications are not recommended during pregnancy or breastfeeding
However, a slight numerical increase in suicidal ideation was observed among liraglutide recipients, with nine cases (0.3%) in the liraglutide group compared to two cases (0.1%) in the placebo group [71]
Retatrutide is an investigational GIP, GLP-1, and glucagon triple receptor agonist not yet approved by the MHRA or EMA
Tirzepatide: From Phase 3 to Pharmacy in 2.5 Years Eli Lilly started the SURMOUNT trial program for tirzepatide in late 2020
Retatrutide's primary mechanism of action involves modulating the activity of the endocannabinoid system, a complex network of receptors and signaling molecules that play a crucial role in maintaining homeostasis within the body
Shaking creates foam and air bubbles that can denature the peptide through mechanical stress